LOTTE Biologics Completes Songdo Plant 1 Construction
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...
DUBLIN, Ireland and SAN ANTONIO, Texas, May 13, 2026 ICON plc announced a major expansion of its U.S. early...
